Asia
The FDA issued warning letters to Lupin for two of its manufacturing facilities in Goa and Pithampur, Indore.
Takeda inked a collaboration deal to develop and commercialize Portal’s needle-free drug delivery device for use with some of Takeda’s biologic medicines.
The new Ethicon factory has attracted a total investment of $180 million.
The 3-year project aims to lower the cost of manufacturing mAbs significantly - to $5/g.
Shares of Teva are up more than 5 percent this morning after Israeli media reported billionaire businessman Len Blavatnik is considering taking a large stock position in the pharma giant.
Fosun Pharma will pay up to $98M to buy the 69% of Henlix Biotech it doesn’t already own.
Annoroad raised $100M in a Series C financing, led by SAIF Partners and joined by SBCVC, Shenzhen GTJA Investment Group and Ping An Ventures.
EyeOP1 is an high-intensity focused ultrasound device that is the first non-invasive treatment for glaucoma in China.
The acquisition is expected to close by the end of 2017.
PRESS RELEASES